Evidence map›Paper›PMID 32795333›Full record

ArticleJournal of experimental & clinical cancer research : CR2020

A SNP-mediated lncRNA (LOC146880) and microRNA (miR-539-5p) interaction and its potential impact on the NSCLC risk.

Tienan Feng, Nannan Feng, Tengteng Zhu, Qiang Li, Qi Zhang, Yu Wang, Ming Gao, Baosen Zhou, Herbert Yu, Min Zheng and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of experimental & clinical cancer research : CR, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. LncRNANon-coding RNA research · 2025
    Article
  6. Role of ENO1 and its targeted therapy in tumors.Journal of translational medicine · 2024
    Review
  7. Single nucleotide variants in lung cancer.Chinese medical journal pulmonary and critical care medicine · 2024
    Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Pyroptosis-related genesFrontiers in genetics · 2023
    Article
  14. Article
  15. Review
  16. Article
  17. Genetic Variations ofPharmacogenomics and personalized medicine · 2022
    Article
  18. Article
  19. Web tools to perform long non-coding RNAs analysis in oncology research.Database : the journal of biological databases and curation · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Tienan FengHongqiao International Institute of Medicine, Shanghai Tongren Hospital/Clinical Research Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Nannan FengHongqiao International Institute of Medicine, Shanghai Tongren Hospital/Clinical Research Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Tengteng ZhuHongqiao International Institute of Medicine, Shanghai Tongren Hospital/Clinical Research Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Qiang LiHongqiao International Institute of Medicine, Shanghai Tongren Hospital/Clinical Research Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Qi ZhangHongqiao International Institute of Medicine, Shanghai Tongren Hospital/Clinical Research Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Yu WangHongqiao International Institute of Medicine, Shanghai Tongren Hospital/Clinical Research Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Ming GaoKey Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, 300060, China.
Baosen ZhouDepartment of Epidemiology, School of Public Health, China Medical University, Shenyang, 110013, China.
Herbert YuCancer Epidemiology Program, University of Hawaii Cancer Center, 701 Ilalo Street, Honolulu, HI, 96813, USA.
Min ZhengTongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200336, China.
Biyun QianHongqiao International Institute of Medicine, Shanghai Tongren Hospital/Clinical Research Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. qianbiyun@sjtu.edu.cn.
Tongren Hospital · CNShanghai Jiao Tong University · CNChengdu Medical College · CNChina Medical University · CNTianjin Medical University Cancer Institute and Hospital · CNUniversity of Hawaii Cancer Center

Funding

National Natural Science Foundation of China 81602929National Natural Science Foundation of China 81973135Shanghai Jiao Tong University Medical and Industrial Cross Project YG2017QN70Startup Fund for Youngman Research at SJTU 17X100040015Tianjin Key Research and Development Program Science and Technology Support Key Projects 17YFZCSY00690
6 · The paper itself

Abstract

backgroundMany cancer-associated single nucleotide polymorphisms (SNPs) are located in the genomic regions of long non-coding RNAs (lncRNAs). Mechanisms of these SNPs in connection to cancer risk are not fully understood.

methodsAssociation of SNP (rs140618127) in lncRNA LOC146880 with non-small cell lung cancer (NSCLC) was evaluated in a case-control study of 2707 individuals. The mechanism of the SNP's biologic influence was explored with in vitro and in vivo experiments, including plasmid transfection, siRNA knockdown, flow cytometry assessment, and assays of cell proliferation, migration, invasion, and colony formation.

resultsAssociation analysis showed that A allele of SNP rs140618127 was associated with low risk of NSCLC in the Chinese population. Lab experiments indicated that SNP rs140618127 contained a binding site for miR-539-5p and the binding between miR-539-5p and LOC146880 resulted in declined phosphorylation of an oncogene, ENO1. The reduced phosphorylation of ENO1 led to decreased phosphorylation of PI3K and Akt, which is further linked to the decline in cell proliferation and tumor progression.

conclusionThe study demonstrates that SNP rs140618127 in lncRNA loc146880 provides an alternate binding site for microRNA miR-539-5p which affects the phosphorylation of ENO1 and activation of the PI3K and Akt pathway.

Indexed as

Polymorphism, Single NucleotideAnimalsApoptosisBiomarkers, TumorCarcinoma, Non-Small-Cell LungCase-Control StudiesCell MovementCell ProliferationDNA-Binding ProteinsFemaleGene Expression Regulation, NeoplasticHumansLung NeoplasmsMaleMiceMice, Inbred BALB CBiomarkers, TumorDNA-Binding ProteinsENO1 protein, humanMicroRNAsMIRN539 microRNA, humanPhosphopyruvate HydrataseRNA, Long NoncodingTumor Suppressor ProteinsENO1lncRNAmiRNANSCLCSNP

Identifiers

PMID32795333
PMCPMC7427888
OpenAlexW3049289330

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.